Navigation Links
Study Suggests that NGAL Identifies Acute Kidney Injury Early in ICU Patients
Date:10/5/2009

arding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the expected benefits, and the potential market for, the Triage NGAL Test. These statements reflect Inverness' current views with respect to future events and are based on management's current assumptions and information currently available. Actual results may differ materially due to numerous factors, including without limitation, the potential market acceptance of the Triage NGAL Test or other NGAL tests; the ability of Inverness to successfully develop and commercialize such products; the impact of regulatory changes or developments; the development and commercialization by others of competing products or alternative technologies; the ability of Inverness to supply sufficient quantities of the product; conditions in the financial markets; the intensely competitive environment in Inverness' markets it products, and the risks and uncertainties described in Inverness' annual report on Form 10-K, as amended, for the year ended December 31, 2008, and other factors identified from time to time in its periodic filings with the Securities and Exchange Commission. Inverness undertakes no obligation to update any forward-looking statements contained herein.

SOURCE Inverness Medical Innovations, Inc.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Bundling Two Generic Low-Cost Heart Drugs Prevents Heart Attack and Stroke in Large, Diverse Population, Observational Clinical Study Shows
2. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
3. Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
4. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
5. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
6. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
7. General Practitioners Write Most Prescriptions for Mental Health Drugs, According to Study from Thomson Reuters and SAMHSA
8. Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
9. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
10. Mardil, Inc. Announces Positive Preliminary Results of Pilot Study With BACE(TM) Device at Annual TCT Conference
11. AVAC Praises Thai AIDS Vaccine Trial Collaborators and Volunteers for Historic Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...
(Date:11/20/2009)...swire-FirstCall/ -- BD (Becton, Dickinson and Comp... of its acquisition of HandyLab, Inc., an Ann Arbo...ctures molecular diagnostic assays and automation ...unced an exclusive agreement for BD to develop and...guar(TM) platform, the first fully integrated mole...
(Date:11/20/2009)...re-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Boa...wn as DOR BioPharma, Inc., a late-stage biotechnol...consortium to develop thermostable technology to a.... Soligenix received a $9.4 million grant from the...ases (NIAID), a division of the National Institute...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 1Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 2Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 3Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 4Communication problems in dementia care cause physical strain 57029 1Communication problems in dementia care cause physical strain 57029 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 1Diabetes drug kills cancer stem cells in combination treatment in mice 9909 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 3
...cation is June 3, 2009 - , , EXTON, Pa., Feb. 3 ...d (Nasdaq: VPHM ) today announced that the U.S. ...ority review for Cinryze C1 Inhibitor (human) as a...ema (HAE). The supplemental Biologics License App...1, 2008, was based on a re-analysis and resubmiss...
...ch designed to help improve medication adherence t..., WOONSOCKET, R.I., Feb. 3 /PRNewswire/ -- A s... found that nearly half of patients hospitalized f...d drug therapies, significantly increasing their r...s. The study found that among those patients who w...
Other Medicine Technology:FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 3CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 4
(Date:11/20/2009)...ogist Closer to Understanding Brain Wiring and Dis...wire/ -- Dr. Jeremy Schmahmann, Professor of Neuro...the Massachusetts General Hospital in Boston, on T...esearch on the new field of study called "Connecti..., Dr. Schmahmann is an award-winning leader in t...
(Date:11/20/2009)...Nov. 20 The United Stat... to make essential changes its health reform bill ...funding and conscience protection on abortion, pro...ude strong provisions for adequate affordability. ...ll an "enormous disappointment" that creates new a...
(Date:11/20/2009)... Nov. 20 Rates of infect...ed in late October, but the pandemic flu virus con...age groups, including the elderly, according to a ...: DGX ), the world,s leading provider of diagnos...ts most recent Quest Diagnostics Health Trends(TM)...
(Date:11/20/2009)...ael, November 20 Cardio ...ww.CVSLMEDICAL.COM , a leading,developer of advanc...ced that,the company,s Board of Directors has deci...ada and the Far East for its proprietary next-gene...gioplasty (PCTA) procedures. , Cardio Vas...
(Date:11/20/2009)...v. 20 SIRIUS XM Radio ...dcast Doctor Radio Reports: What Every Women Ne... hosted by veteran journalist Perri Peltz. ,, ...19/NYTU044LOGO ) ,, Doctor Radio Reports: Wh...l air November 21 live at 10:00 am ET on Doctor ...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...ecently approved of a new prescription treatment f...s almost everybody. Gingivitis is an inflammation ...ing gums. It is believed that plaque-forming bacte...uction in the inflammation associated with gingivi...
...rth weight may be at heightened risk// of cardiova...as well as for the fathers. In a research don...rt that poor fetal growth that leads to low birth ... children with low birth weight may also be at mor...
...cancers are preventable by changes in our life sty...osing excess weight also helps. To lose weight one...ncer Institute in US recently approved the dietary...ioxidants and protect the DNA from damage by free-...
...uggested that patients going for PET or CT scan sh...nterferes with PET/CT image results when there is ...university presented his study that looks at the ...l conference held this month in Toronto. Usua...
...er pills based treatment resulted in the lowest ra... the groups of African-Americans and Americans. No...ugs can benefit the patients with diabetes who suf...atment to Prevent Heart Attack Trial (ALLHAT) stud...
...f Internal Medicine obese women with breast cancer... study was conducted to determine treatment patter...nt chemotherapy for breast cancer. Adjuvant chemot... Data on patients with early stage breast canc...
Other Medicine News:Health News:Top Ten Super Food Items That Can Help In Avoiding Cancer , 2Health News:Obese women with breast cancer may be under treated., 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: